Zemiglo 50 mg Tablet

Zemiglo 50 mg Tablet belongs to the class of 'anti-diabetic medicines' primarily used to improve blood sugar control in adults with type 2 diabetes mellitus (non-insulin-dependent diabetes). Diabetes mellitus is a metabolic disease that causes high blood sugar levels. It occurs when the insulin (a hormone produced by the beta cells of the pancreas) is resistant in breaking the glucose to produce energy (insulin resistance), or the pancreas (an organ behind the stomach) produces little or no insulin at all.

Zemiglo 50 mg Tablet contains Gemigliptin that belongs to the class of 'dipeptidyl peptidase-4 (DPP-4) inhibitors'. Gemigliptin works by increasing incretin hormones that stimulate a decrease in blood glucose levels. It also decreases glucagon secretion, which raises the concentration of glucose levels. Thus, it reduces postprandial hyperglycemia (a rise in blood sugar levels after meals).

Your doctor will decide the dose and duration based on your medical condition. Some common side effects of Zemiglo 50 mg Tablet include headache, nausea, diarrhoea, stomach discomfort, constipation, and dry mouth. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor. 

Before starting Zemiglo 50 mg Tablet , let your doctor know if you have a history of heart, kidney or liver diseases. Do not take or stop this medicine if the doctor did not advise you. It is advised to limit your alcohol intake while using Zemiglo 50 mg Tablet to avoid low blood sugar levels further. Pregnant and breastfeeding women should consult their doctor before starting Zemiglo 50 mg Tablet . Zemiglo 50 mg Tablet may cause hypoglycaemia (low blood sugar levels), affecting your driving ability; hence drive or operate machinery only when you feel better. Zemiglo 50 mg Tablet is not recommended for children and adolescents under 18 years of age.

Zemiglo 50 mg Tablet comprises 'Gemigliptin.' It increases incretin hormones that stimulate a decrease in blood glucose levels. It also decreases glucagon secretion, which raises the concentration of glucose levels. Thus, it improves glycemic control in postprandial hyperglycemia.

Brief your medical history to the doctor if you have any heart, kidney or liver diseases or type 1 diabetes before starting Zemiglo 50 mg Tablet . It is advised to limit your alcohol intake while using Zemiglo 50 mg Tablet to avoid any interactions or worsening of side effects. Pregnant and breastfeeding women should consult their doctor before starting this medication. Zemiglo 50 mg Tablet may cause hypoglycaemia; hence drive and operate machinery only when you feel better. This medicine is not recommended for children and adolescents under 18 years of age.

It is advised to monitor your blood sugar levels regularly.